Close Menu

In a preprint article on bioRxiv, Memorial Sloan Kettering Cancer Center's Maria Jasin, Harvard's George Church, and their colleagues sound a note of scientific caution on a recent Nature study that reported using the gene-editing tool CRISPR/Cas9 to correct a heart disease mutatio

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

US tax agency says 23andMe's genetic health test can be claimed as a medical expense for tax purposes, the Wall Street Journal reports.

The Guardian reports that some UK physicians are calling for increased regulation of direct-to-consumer genetic tests.

Two Democratic lawmakers argue at USA Today that independent science is under attack by the Trump Administration.

In PLOS this week: networks of genes co-expressed in depression, role of minichromosome maintenance genes in lung adenocarcinoma, and more.